INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845P908. A total of 2 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,611,000 | +350.2% | 447 | +347.0% | 0.24% | +526.3% |
| Q3 2017 | $580,000 | -97.6% | 100 | -88.1% | 0.04% | -96.2% |
| Q1 2015 | $23,774,000 | +1726.0% | 843 | +1432.7% | 0.99% | +1880.0% |
| Q3 2014 | $1,302,000 | -19.1% | 55 | -19.1% | 0.05% | -27.5% |
| Q2 2014 | $1,609,000 | – | 68 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 447 | $2,611,000 | 0.24% |
| GROUP ONE TRADING, L.P. | 92,700 | $5,416,000 | 0.04% |
| SIMPLEX TRADING, LLC | 267 | $18,000 | 0.00% |